SmartLabs’ Post

This week in the pharmaceutical industry, strategic partnerships and investments come to the fore. We have compiled the most prominent developments for you. 👇 Enjoy your reading!   ✅ #EliLilly and HAYA Therapeutics enter metabolic condition partnership worth $1bn. https://lnkd.in/d4yFbbQG ✅ #ArsenalBio secures $325m to develop cell therapy programmes. https://lnkd.in/dtZk82kx ✅ German life science company #Evotec has announced a collaboration with X-Chem to accelerate early-stage drug discovery-leveraging technology. https://lnkd.in/d_XGzQt2 ✅ Eli Lilly and EVA Pharma to expand baricitinib access in Africa. https://lnkd.in/dkNKrXDE ✅ Gene therapy trial facilitates major vision improvement. https://lnkd.in/eQ8VvEHv #pharmanews #strategyconsulting #pharmaceuticals #fitminds

🎉 ProofPilot's webinar is happening NOW!! 🎉 Join our esteemed panelists who chat innovation in small pharma and biotech –sharing how they know firsthand that innovation isn't just for big companies. We're live NOW, 12 pm EST! Register and join here 👉https://hubs.la/Q02xKT8j0 Join us with Rezolute, Inc., Terns Pharmaceuticals, Geneos Therapeutics, and Yonalink!! #clinicalresearch #healthtechnews #clinicaltrialsday

Don't miss out on this panel covering "Strategies and Lessons Learned From Regulatory Inspections" at #FierceTMF 2024. 📣 Speakers from Agios Pharmaceuticals, Just in Time GCP, Daiichi Sankyo, Inc., Larimar Therapeutics Inc., Alnylam Pharmaceuticals, and Takeda will dive into the world of inspection readiness by exploring how strategies vary across the biotech and pharma landscape and how they are influenced from regulatory shifts and therapeutic advances. From pre- to post-pandemic inspection practices, to the future of the industry through a TMF lens, they breakdown how to integrate new tech, legislative changes, gene therapies, and DCTs into a forward-thinking readiness framework. Secure 50% off Your Fierce TMF Summit Pass | Only 25 Passes Available: Use Promo Code LAST25  🔗 https://lnkd.in/ezgVgn8Z #TMF #FierceTMF #WeAreFierce #FierceBiotech #FiercePharma #Pharma #Biotech

Conceptualization and execution with strategic planning develop an idea into a startup.

💡 Join WEP Clinical for an upcoming webinar to explore the challenges small and mid-sized biotech and pharma companies face in navigating clinical trials for advanced therapies like cell and gene therapies. These trials demand more than technical expertise—they require strategic partnerships and resource management. The featured speakers will discuss regulatory complexities, patient recruitment, logistical hurdles, and how partnering with specialized service providers can optimize trial design, streamline operations, and reduce risks. ➡️ Learn more + register here: https://buff.ly/3MIXuMq #Pharmaceutical #DrugDevelopment #PrecisionMedicine #ClinicalResearch #Biopharma #Biotech #CRO #PatientRecruitment #Regulatory #TherapeuticAreas #Pharma #CellAndGeneTherapy #CellAndGeneTherapies #CGT

Thoughts on this? >> Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference - StockTitan >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #healthcare #competitivemarketing

Read all about Ecolab's approach to the growing demand for cell and gene therapies, supply chain security, sustainability in pharma, and more, here >>

Knowledge is power! BioAgilytix is a contract research organization (CRO) that specializes in bioanalytical testing for pharmaceutical and biotech companies. They provide services to support drug development, particularly in the areas of biologics, biomarkers, and cell and gene therapies. Their expertise includes large molecule bioanalysis, which is critical for developing complex therapeutic products. BioAgilytix has been responsible for conducting independent tests to validate the efficacy and safety of ASEA’s redox signaling products. ASEA relies on BioAgilytix to ensure that their products meet high-quality standards and that the claims they make about redox signaling molecules are scientifically supported. This relationship lends credibility to ASEA’s product offerings, as the research is done by an external, trusted laboratory. #healthandwellness #athleticperformance #antiaging

Life Science Companies, CMO's, CRO's, Packaging Labeling Companies, 3PL global Distributors. Take advantage of our Formal, Comprehensive Audit services to ensure your Pharmaceuticals, Biologics, or Cell and Gene Therapy products are flowing through the Supply Chain with the highest state of Resilience. #supplychaininnovation #supplychainmanagement #lifesciences #globallogistics #tradecompliance #cgmp #productsecurity

Creating a scalable and reproducible product process is the ultimate goal for any developer in the cell therapy field. However, achieving this is not an easy task. Luca Alberici, head of our Cell and Gene Center of Excellence in Milan, shares key strategies for developing a flexible end-to-end cell therapy manufacturing approach. Check out our on-demand webinar to learn about various manufacturing systems, essential steps, and equipment, as well as effective scale-up and scale-out strategies. (Link in the comments) #AGCBio #CDMO #biotech #pharmaceuticals #LifeScience #Biotechnology #advancedtherapies #Biopharmaceuticals